1Zacher L 见:Gate RH 主编 汪明明 崔速南 译.社区获得性肺炎:头号公敌[A].见:Gate RH,主编,汪明明,崔速南,译.美国最新临床医学问答感染性疾病[C].北京:海洋出版社,2000.431-439.
2Finch RG, Woodhead MA. Practical considerations and guidelines for the management of community-acquired pneumonia. Drugs, 1998,55:31-45.
3Battleman DS,Callahan M,Thaler HT. Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia:link between quality of care and resource utilization. Arch Intern Med ,2002,162:682-688.
4Dudas V, Hopefl A, Jacobs R, et al. Anti-microbial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. Ann Pharmacother,2001,34:446-452.
5Meehan TP, Fine M J, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA, 1997,278 :2080-2084.
6Marrie TJ, Lau CY, Wheeler SL, et al. A controlled trim of a critical pathway for treatment of community-acquired pneumonia. Capital Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA,2000,283:749-755.
7Castro-Guardiola A, Viejo-Rodriguez AL, Soler-Simon S, et al. Efficacy and safety of oral and early-switch therapy for communityacquired pneumonia:a randomized controlled trial. Am J Med ,2001,111:367-374.
8Siegel RE, Halpem NA, Almenoff PL, et al. A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest, 1996,10:965-971.
9Moran GJ. New directions in antiinfective therapy for community-acquired pnemnonia in the emergency department. Pharmacotherapy,2001,21 (7 Pt 2) :95S-99S.
10Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance : a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med, 2000,160:1399-1408.
